Crude's Tumble Ushers in a Shift to Slower Global Growth
Will Obama Double the SEC's Budget?
Merkel's Refugee Plan Finds Little Support
I Be Up in the Gym Working on My Fitness
Here's Why We're Heading into a Bear Market...
Cameron Reynolds of VolitionRX Ltd. ($VNRX) sits down with Equities.com to discuss the company's blood-based diagnostic tests for cancer.
You have to be logged in to leave a comment.
I'm sorry, but in order to complete what you're trying to do, you must be logged in.
© 2015 Equities
*All dates and time are being displayed in Eastern Standard Time (EST).